Table 2.
Regularity of Vessel Lumen
| |||||
Walking pace | <3 mph | ≥3 mph | P-trend1 | ||
Model 12 | 1.0 (ref.) | 1.52 (1.13, 2.05) | 0.006 | ||
Model 23 | 1.0 (ref.) | 1.52 (1.10, 2.09) | 0.01 | ||
Model 34 | 1.0 (ref.) | 1.59 (1.11, 2.27) | 0.01 | ||
Vigorous Physical Activity | <1 h/wk | 1 to <3 h/wk | ≥3 h/wk | ||
Model 12 | 1.0 (ref.) | 1.32 (0.93, 1.89) | 0.93 (0.62, 1.39) | 0.87 | |
Model 23 | 1.0 (ref.) | 1.24 (0.86, 1.81) | 0.78 (0.51, 1.20) | 0.36 | |
Model 34 | 1.0 (ref.) | 1.17 (0.78, 1.75) | 0.89 (0.56, 1.41) | 0.68 | |
Non-vigorous Physical Activity | <1.5 h/wk | 1.5 to <3.5 h/wk | 3.5 to <7 h/wk | ≥7 h/wk | |
Model 12 | 1.0 (ref.) | 0.90 (0.59, 1.38) | 1.22 (0.79, 1.89) | 1.00 (0.65, 1.54) | 0.85 |
Model 23 | 1.0 (ref.) | 0.91 (0.59, 1.41) | 1.14 (0.72, 1.80) | 0.86 (0.55, 1.35) | 0.53 |
Model 34 | 1.0 (ref.) | 0.71 (0.43, 1.15) | 0.86 (0.52, 1.42) | 0.75 (0.46, 1.25) | 0.55 |
Vessel Area | |||||
Walking pace | <3 mph | ≥3 h/wk | |||
Model 12 | 1.0 (ref.) | 1.24 (0.93, 1.67) | 0.15 | ||
Model 23 | 1.0 (ref.) | 1.24 (0.90, 1.71) | 0.18 | ||
Model 34 | 1.0 (ref.) | 1.48 (1.04, 2.12) | 0.03 | ||
Vigorous Physical Activity | <1 h/wk | 1 to <3 h/wk | ≥3 h/wk | ||
Model 12 | 1.0 (ref.) | 0.98 (0.69, 1.40) | 0.87 (0.58, 1.31) | 0.52 | |
Model 23 | 1.0 (ref.) | 0.92 (0.63, 1.33) | 0.82 (0.54, 1.26) | 0.36 | |
Model 34 | 1.0 (ref.) | 0.83 (0.55, 1.24) | 0.70 (0.44, 1.11) | 0.12 | |
Non-vigorous Physical Activity | <1.5 h/wk | 1.5 to <3.5 h/wk | 3.5 to <7 h/wk | ≥7 h/wk | |
Model 12 | 1.0 (ref.) | 1.11 (0.72, 1.70) | 1.04 (0.68, 1.61) | 0.90 (0.58, 1.39) | 0.40 |
Model 23 | 1.0 (ref.) | 1.13 (0.73, 1.76) | 0.95 (0.60, 1.49) | 0.78 (0.50, 1.23) | 0.12 |
Model 34 | 1.0 (ref.) | 1.18 (0.72, 1.92) | 0.93 (0.57, 1.54) | 0.86 (0.52, 1.42) | 0.31 |
Microvessel Density | |||||
Walking pace | <3 mph | ≥3 h/wk | |||
Model 12 | 1.0 (ref.) | 1.10 (0.82, 1.47) | 0.55 | ||
Model 23 | 1.0 (ref.) | 1.02 (0.74, 1.41) | 0.89 | ||
Model 34 | 1.0 (ref.) | 1.07 (0.75, 1.53) | 0.70 | ||
Vigorous Physical Activity | <1 h/wk | 1 to <3 h/wk | ≥3 h/wk | ||
Model 12 | 1.0 (ref.) | 1.48 (1.04, 2.12) | 0.95 (0.63, 1.42) | 0.97 | |
Model 23 | 1.0 (ref.) | 1.53 (1.05, 2.22) | 0.99 (0.64, 1.51) | 0.87 | |
Model 34 | 1.0 (ref.) | 1.55 (1.03, 2.32) | 1.03 (0.65, 1.64) | 0.76 | |
Non-vigorous Physical Activity | <1.5 h/wk | 1.5 to <3.5 h/wk | 3.5 to <7 h/wk ≥7 h/wk | ||
Model 12 | 1.0 (ref.) | 0.91 (0.59, 1.39) | 0.74 (0.48, 1.15) | 0.97 (0.63, 1.50) | 0.85 |
Model 23 | 1.0 (ref.) | 0.92 (0.59, 1.42) | 0.73 (0.47, 1.16) | 0.92 (0.58, 1.44) | 0.89 |
Model 34 | 1.0 (ref.) | 0.79 (0.49, 1.29) | 0.61 (0.37, 1.01) | 0.80 (0.48, 1.31) | 0.68 |
p-trend calculated by modeling the median of the exposure categories as a continuous term.
Model 1: Ordinal logistic regression with the dependent variable categorized in quartiles and adjusted for age at diagnosis.
Model 2: Model 1 adjusted for body mass index at diagnosis (<25, 25-29.9, 30+ kg/m2), smoking status at diagnosis (never, former, current), tissue source (radical prostatectomy, trans urethral resection of the prostate), lycopene intake at diagnosis (quartiles), vitamin E intake at diagnosis (quartiles), and regular aspirin use at diagnosis (yes/no). Additionally, the types of activity are adjusted for one another. Model 2 includes the 546 men who had complete data on all covariates included in the model.
Model 3: Model 2 adjusted for pathologic stage (T1/T2 vs. T3/T4), Gleason sum (2-6, 7, 8-10), and diagnostic prostate specific antigen level (ng/ml). Model 3 includes 465 men who had complete data on all covariates included in the model.